China Bio-services & Database Package
| Publication Date | May 2006 |
|---|---|
| Publisher | General Biologic |
| Product Type | Report |
| Pages | 90 |
| ISBN Number | not applicable |
| Product Code | GBI00002 |
Summary
China Bio-services is an essential resource for biotechnology and pharmaceutical companies aiming to increase R&D productivity and reduce costs through outsourcing to bio-services companies. This fully updated report includes industry analysis and provides information on 74 Chinese and joint venture biotech service firms, case studies, and company profiles on selected leaders. This report will benefit pharmaceutical and biotechnology companies, bio-services companies, biotech tool suppliers, investors, and others requiring information concerning biotech services in China.
China Bio-service database includes 70+ Chinese bio-service providers. Service categories include cell biology, molecular biology, immunology, animal model and microarray. Each provider in the database includes:
- I. Company name in English and Chinese
- II. Address
- III.Founding date
- VI.Human resource number
- V.Contact person name
- VI.Services available
- VII.Website address
Content
- I. Introduction
- History
- Business environment
- Educated workforce
- Labor and resource costs
- Culture of entrepreneurialism
- Returnees
- Investment and funding
- Parks and incubators
- II. Overview of players
- Players segmentation
- Four types of players
- Geography distribution
- Company-scale distribution
- III. Industry internal relationships
- IV.Market sources
- V. Factors influencing the industry
- VI. Key customer concerns
- Price
- Turnaround
- Instruments, reagents, and consumables
- Professionalism
- Cell related services
- Molecular biology services
- Immunology services
- Animal model services
- Microarray services S
- Equipment dependent services
- Equipment independent services
- IX. Trends Opportunities for multinationals Case studies
- X. Service provider profiles
- XI. Directory
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















